- This event has passed.
Information session for stakeholders on EU4Health joint action on support to coordinated and expedited assessment of clinical trials for COVID-19 therapeutics
February 3 @ 10:00 am - 12:00 pm
An EU4Health Joint action for expedited assessment of multinational COVID19 trials will start from February 2022. In order to provide potential developers and clinical trial sponsors with information about this joint action, the coordinators and the steering committee has organised an info session to stakeholders, which will take place on 3 February from 10:00 to 12:00 CET (see attached programme).
Please note that the scope is limited to COVID19 therapeutic trials submitted under the Clinical Trials Regulation ((EU) 536/2014).
We would like to invite you to join this information session and to share the following link with your relevant stakeholders to allow them to register to this event via the link below:
Link: https://scic.ec.europa.eu/ew/register/dgscic/JA_02_22/e/lk/g/36170/k/ (see attached instruction on how to create an account)EU Login tutorial (short)
The deadline for registration is 31 January 2022.
The Joint Action has been set up to implement the EU Strategy on COVID19 therapeutics: https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:52021DC0355R(01)&from=EN.
It will be financed under EU4Health managed by HADEA: https://ec.europa.eu/health/funding/eu4health-2021-2027-vision-healthier-european-union_en